-
公开(公告)号:US20190038624A1
公开(公告)日:2019-02-07
申请号:US16053800
申请日:2018-08-03
IPC分类号: A61K31/506 , A61P25/16 , A61P25/28 , A61K9/00
摘要: The present disclosure relates to a method for treating or alleviating a symptom of MSA, comprising administering a therapeutically effective amount of an abelson (Abl) tyrosine kinase inhibitor to a subject in need thereof.